Cheryl Guttman Krader is a contributor to Dermatology Times, Ophthalmology Times, and Urology Times.
Adolescent acne therapies benefit younger childrenDecember 2nd 2020
A recent paper suggests younger children with acne vulgaris should be treated the same as adolescents. This includes utilizing combination therapies that may consist of topic retinoids, benzoyl peroxide and other nonantibiotic agents in combination with antibiotics.
Strategies for choosing and using neuromodulatorsNovember 20th 2020
All safe and effective, the four neuromodulators with cosmetic indications have nuanced differences worth considering. Seth Matarasso, M.D., explains the benefits of these cosmetic neuromodulators, and reveals how to know when to choose the right one.
Robotic-controlled laser advances body contouringNovember 18th 2020
A novel robotic-controlled 1064-nm laser brings efficiency and precision to body contouring. The clinical trial supporting FDA clearance of the device showed its effectiveness based on blinded photographic assessments, ultrasound measurements and circumferential assessments.
Case series draws attention to phenotype of acne scarringSeptember 10th 2020
A retrospective review of patients seen in an academic dermatology clinic over a one-year period identified 20 individuals with nasal papules in association with acne, which are thought to represent scarring sequelae. The condition is underrecognized, researchers say and requires further research to better understand.
COVID-19 safety guidelines provide protocols to protect staff, patientsAugust 27th 2020
Safety guidelines from the European Academy of Facial Plastic Surgery Aesthetic Medicine Focus Group describe protocols for protecting clinic staff and patients from COVID-19. Recommendations include procedures before, during and after a patient visit, as well as necessary forms.
Phenotypes inform management optionsAugust 20th 2020
Many patients with rosacea have features that overlap more than one subtype of the condition. A recent publication serves as a compliment to the classification guide with the intention of guiding treatment and management options based on individual patient features.
Specialized skincare regimen improves rosacea symptomsAugust 14th 2020
Effects of a specialized skincare regimen for sensitive and redness-prone skin were investigated in an eight-week, prospective, controlled clinical trial enrolling 60 patients with rosacea. The intervention was associated with improvements in objectively measured erythema, rosacea symptoms, and health-related quality of life.
Collaboration makes progresses standards for implementing AIAugust 11th 2020
The International Skin Imaging Collaboration is an academic and industry partnership designed to facilitate the clinical application of digital skin imaging, with an initial focus on melanoma. The group is developing standards for dermatologic imaging and building a public archive of clinical and dermoscopic images for use in developing artificial intelligence diagnostic algorithms.
JAK-STAT inhibition an attractive target for atopic dermatitis drugsJune 15th 2020
Jonathan H. Zippin, M.D., Ph.D., explains what existing drugs and investigational compounds that inhibit the JAK-STAT pathway are being investigated as treatment for atopic dermatitis, alopecia areata, vitiligo and psoriasis.
Recognition of patients with hereditary melanoma is important not only because these individuals require careful surveillance for future primary melanomas, but also because they may be predisposed to multiple other types of malignancies because of their genetic mutation, says Hensin Tsao, M.D., Ph.D.